Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05391347
Other study ID # Orange oil aromatherapy
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2021
Est. completion date January 30, 2022

Study information

Verified date May 2022
Source Istanbul Aydin University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized controlled experimental study was conducted prospectively with 80 patients with hematological malignancies were treated in the adult bone marrow transplant unit and adult hematology service of a private hospital between May 2021 and January 2022. Orange oil inhalation used in aromatherapy was applied to patients in the intervention group. Visual Analogue Scale and the State-Trait Anxiety Inventory used for data collection.


Description:

Introduction: Invasive interventions such as peripheral intravenous cannula and port needle placement, and blood collection are often required for both inpatient and outpatient follow-up patients with hematological malignancies and hematopoietic stem cell transplantation patients. This long and difficult treatment process causes anxiety and emotional disorders in most patients. Although invasive initiatives in the treatment and monitoring process are widely implemented, they lead to pain, anxiety and discomfort, which is often ignored. This study conducted to assess the effect of orange oil inhalation used in aromatherapy on pain and anxiety levels in invasive interventions to treat patients with hematological malignancies and hematopoietic stem cells transplantation. Methods: This randomized controlled experimental study was conducted prospectively with 80 patients with hematological malignancies were treated in the adult bone marrow transplant unit and adult hematology service of a private hospital between May 2021 and January 2022. Orange oil inhalation used in aromatherapy was applied to patients in the intervention group. Visual Analogue Scale and the State-Trait Anxiety Inventory used for data collection.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date January 30, 2022
Est. primary completion date January 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients older than 18 years old, - without communication problems, - without allergy and respiratory system problems, - who agreed to participate in the study Exclusion Criteria: - severe hypotension - other allergic complications that made it difficult for patients to continue the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Orange oil aromatherapy
5 minutes before the invasive procedure, 3 ml of orange oil were dripping onto the sponge, and the patient was told to breathe slowly at a distance of 3 cm and to smell during the process.

Locations

Country Name City State
Turkey Istanbul Aydin University Istanbul

Sponsors (3)

Lead Sponsor Collaborator
Istanbul Aydin University Acibadem Atunizade Hospital, Sinop University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analog Scale (VAS) Visual Analog Scale; A scale applied on a straight line by marking a millimeter horizontal or vertical line. In this line, the 0 cm dot means "No Pain", while the 10 cm dot means "very bad pain". The patient marks the pain level on the scale. The marked point is measured using a tape measure and scored. Most studies so far show that visual analogue scale (VAS) is a reliable tool to use to assess the pain level 5 minutes before the aromatherapy
Primary The State-Trait Anxiety Inventory (STAI) In scale; there are 20 questions in the state area. It provides a four-point Likert type measurement. Scoring varies between 20-80. Although there is not a clear cut-off point, 39-40 points are often considered as the cut-off point of inventory. High score indicates high level of anxiety 5 minutes before the aromatherapy
See also
  Status Clinical Trial Phase
Recruiting NCT06148610 - Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Completed NCT02212236 - Psychological Intervention for Distress During HSCT Phase 2
Completed NCT00023530 - Blood and Marrow Transplant Clinical Research Network N/A
Completed NCT01466335 - An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers Phase 1
Withdrawn NCT02682953 - Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers Phase 2
Completed NCT00775632 - Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants Phase 2
Completed NCT00048256 - Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates N/A
Completed NCT00004994 - Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant N/A
Completed NCT04039100 - Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease N/A
Completed NCT04535570 - Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation
Recruiting NCT06118853 - Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT N/A
Active, not recruiting NCT01016093 - Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients Phase 2/Phase 3
Completed NCT01015183 - Prevention Chemotherapy Induced Mucositis by Zinc Sulfate Phase 2/Phase 3
Completed NCT00843180 - Massage for Pediatric Oncology N/A
Completed NCT00000591 - T-Cell Depletion in Unrelated Donor Marrow Transplantation Phase 3
Completed NCT04474730 - Physical Activity Monitoring Among BMT Patients N/A
Completed NCT02733744 - Fecal Microbiota Transplantation After HSCT Early Phase 1
Active, not recruiting NCT02319226 - Toward Immune Biomarkers for Tolerance and GvHD in Humans
Recruiting NCT00673348 - Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations N/A
Completed NCT00005556 - Retention of Bone Marrow Donors in a National Registry N/A